Literature DB >> 18409179

Mutations in the chromatin-associated protein ATRX.

Richard J Gibbons1, Takahito Wada, Christopher A Fisher, Nicola Malik, Matthew J Mitson, David P Steensma, Alan Fryer, David R Goudie, Ian D Krantz, Joanne Traeger-Synodinos.   

Abstract

ATRX belongs to the SNF2 family of proteins, many of which have been demonstrated to have chromatin remodeling activity. Constitution mutations in the X-encoded gene give rise to alpha thalassemia mental retardation (ATR-X) syndrome and a variety of related conditions that are often associated with profound developmental delay, facial dysmorphism, genital abnormalities, and alpha thalassemia. Acquired mutations in ATRX are observed in the preleukemic condition alpha thalassemia myelodysplastic syndrome (ATMDS). Mutations in ATRX have been shown to perturb gene expression and DNA methylation. This is a comprehensive report of 127 mutations including 32 reported here for the first time. Missense mutations are shown to cluster in the two main functional domains. The truncating mutations appear to be "rescued" to some degree and so it appears likely that most if not all constitutional ATRX mutations are hypomorphs. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18409179     DOI: 10.1002/humu.20734

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  64 in total

Review 1.  Genetic variation in the epigenetic machinery and mental health.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

2.  Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

Authors:  Yuan-Chin Tsai; Todd M Greco; Apaporn Boonmee; Yana Miteva; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2011-12-05       Impact factor: 5.911

3.  Mouse ES cells overexpressing DNMT1 produce abnormal neurons with upregulated NMDA/NR1 subunit.

Authors:  Leonardo D'Aiuto; Roberto Di Maio; K Naga Mohan; Crescenzio Minervini; Federica Saporiti; Isabella Soreca; J Timothy Greenamyre; J Richard Chaillet
Journal:  Differentiation       Date:  2011-04-13       Impact factor: 3.880

4.  A diagnosis of discernment: Identifying a novel ATRX mutation in myelodysplastic syndrome with acquired α-thalassemia.

Authors:  Jedrzej Wykretowicz; Yeohan Song; Brooke McKnight; Sung Won Choi; John Magenau; Radhika Takiar; Paul El Tomb; David Ginsburg; Dale Bixby; Rami Khoriaty
Journal:  Cancer Genet       Date:  2019-01-09

5.  Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

Authors:  Yuan-Chin Tsai; Todd M Greco; Apaporn Boonmee; Yana Miteva; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2012-05       Impact factor: 5.911

6.  Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.

Authors:  Julien Masliah-Planchon; Dominique Lévy; Delphine Héron; Fabienne Giuliano; Catherine Badens; Paul Fréneaux; Louise Galmiche; Jean-Marc Guinebretierre; Cécile Cellier; Joshua J Waterfall; Khadija Aït-Raïs; Gaëlle Pierron; Christophe Glorion; Isabelle Desguerre; Christine Soler; Anne Deville; Olivier Delattre; Jean Michon; Franck Bourdeaut
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

Review 7.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

8.  Epigenetic dysregulation in cancer.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

9.  The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.

Authors:  Arunkumar Dhayalan; Raluca Tamas; Ina Bock; Anna Tattermusch; Emilia Dimitrova; Srikanth Kudithipudi; Sergey Ragozin; Albert Jeltsch
Journal:  Hum Mol Genet       Date:  2011-03-18       Impact factor: 6.150

10.  Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.

Authors:  Naser M Ali; Stefania Niada; Anna T Brini; Mark R Morris; Sathishkumar Kurusamy; Abdullah Alholle; David Huen; Cristina R Antonescu; Franck Tirode; Vaiyapuri Sumathi; Farida Latif
Journal:  J Pathol       Date:  2018-12-27       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.